首页> 外文期刊>Journal of the American Chemical Society >Multifunctional Core-Shell Nanoparticles: Discovery of Previously Invisible Biomarkers
【24h】

Multifunctional Core-Shell Nanoparticles: Discovery of Previously Invisible Biomarkers

机译:多功能核壳纳米粒子:以前不可见的生物标志物的发现。

获取原文
获取原文并翻译 | 示例
           

摘要

Many low-abundance biomarkers for early detection of cancer and other diseases are invisible to mass spectrometry because they exist in body fluids in very low concentrations, are masked by high-abundance proteins such as albumin and immunoglo-bulins, and are very labile. To overcome these barriers, we created porous, buoyant, core-shell hydrogel nanoparticles containing novel high affinity reactive chemical baits for protein and peptide harvesting, concentration, and preservation in body fluids. Poly(N-isopropylacrylamide-co-acrylic acid) nanoparticles were functionalized with amino-containing dyes via zero-length cross-linking amidation reactions. Nanoparticles functionalized in the core with 17 different (12 chemically novel) molecular baits showed preferential high affinities (K_D< 10~(11) M) for specific low-abundance protein analytes. A poly(N-isopropylacrylamide-co-vinylsulfonic acid) shell was added to the core particles. This shell chemistry selectively prevented unwanted entry of all size peptides derived from albumin without hindering the penetration of non-albumin small proteins and peptides. Proteins and peptides entered the core to be captured with high affinity by baits immobilized in the core. Nanoparticles effectively protected interleukin-6 from enzymatic degradation in sweat and increased the effective detection sensitivity of human growth hormone in human urine using multiple reaction monitoring analysis. Used in whole blood as a one-step, in-solution preprocessing step, the nanoparticles greatly enriched the concentration of low-molecular weight proteins and peptides while excluding albumin and other proteins above 30 kDa; this achieved a 10,000-fold effective amplification of the analyte concentration, enabling mass spectrometry (MS) discovery of candidate biomarkers that were previously undetectable.
机译:质谱法看不见许多用于早期检测癌症和其他疾病的低丰度生物标志物,因为它们以非常低的浓度存在于体液中,被高丰度蛋白(如白蛋白和免疫球蛋白)掩盖,并且非常不稳定。为了克服这些障碍,我们创建了包含新型高亲和力反应性化学诱饵的多孔,可浮的核壳水凝胶纳米颗粒,用于蛋白质和肽的收获,浓缩和在体液中的保存。聚(N-异丙基丙烯酰胺-共丙烯酸)纳米粒子通过零长度交联酰胺化反应用含氨基染料进行官能化。在核心中功能化的纳米粒子具有17种不同(化学上新的12种)分子诱饵,对特定的低丰度蛋白质分析物表现出优先的高亲和力(K_D <10〜(11)M)。将聚(N-异丙基丙烯酰胺-共乙烯基磺酸)壳添加至核颗粒。这种壳化学选择性地阻止了源自白蛋白的所有大小的肽的有害进入,而不会阻碍非白蛋白小蛋白和肽的渗透。蛋白质和肽进入核心,被固定在核心中的诱饵以高亲和力捕获。纳米颗粒有效地保护白细胞介素6免受汗液中酶的降解,并使用多重反应监测分析提高了人类尿液中人类生长激素的有效检测灵敏度。用于全血中的一步法,溶液内预处理步骤,纳米粒子极大地丰富了低分子量蛋白质和多肽的浓度,而排除了白蛋白和其他30 kDa以上的蛋白质;这实现了分析物浓度的10,000倍有效放大,从而使质谱(MS)发现了以前无法检测到的候选生物标记。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2011年第47期|p.19178-19188|共11页
  • 作者单位

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States,Department of Analytical Chemistry, Stockholm University, Stockholm 106 91, Sweden,Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanita, Rome 00161, Italy;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States,Department of Analytical Chemistry, Stockholm University, Stockholm 106 91, Sweden,Department of Medicine and Experimental Oncology, University of Turin, 10125 Turin, Italy;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Department of Analytical Chemistry, Stockholm University, Stockholm 106 91, Sweden;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

    Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号